The Fourth Jump

Company Overview

Snapshot

Founded in September 2023 by Yaakov Ezra, The Fourth Jump operates with 1–10 employees. The company is currently in a Pre-Funding stage, focusing on developing its mobile application for headache and chronic pain management.

Business overview

The Fourth Jump develops digital therapeutics for managing headaches and chronic pain exacerbated by stress. The company's core product is the MDTate mobile application, which is based on a treatment method developed by Dr. Yaakov Ezra. This application aims to provide users with tools to control headaches and increase awareness of stress's impact on pain frequency. The Fourth Jump operates within the Health Tech & Life Sciences sector, specifically targeting digital healthcare, patient engagement, and patient remote monitoring markets, serving both consumers and healthcare providers.

Company Intelligence Q&A

What is The Fourth Jump's primary product?

The Fourth Jump's primary product is MDTate, a mobile application designed for the treatment of headaches and chronic pain exacerbated by stress. It is available on both Apple App Store and Google Play.

When was The Fourth Jump founded?

The Fourth Jump was founded in September 2023 by Yaakov Ezra.

What is the current stage of The Fourth Jump's product development?

The Fourth Jump's product, MDTate, is currently in the 'Released' stage, indicating it is available to users.

What problem does The Fourth Jump aim to solve?

The Fourth Jump aims to provide users with a method to gain control over headaches and increase their awareness of how stress influences the frequency of pain, utilizing a treatment method developed by Dr. Yaakov Ezra.

In which sectors does The Fourth Jump operate?

The Fourth Jump operates in the Health Tech & Life Sciences sector, with a focus on Digital Healthcare, Patient Engagement, and Patient Remote Monitoring.